NSC Clinical Evaluation 3

Question 1

During a clinical evaluation, which type of consent must be obtained before releasing substance use treatment records?

Accepted Answer

Specific written consent compliant with 42 CFR Part 2

Answer

42 CFR Part 2 imposes stricter confidentiality requirements on substance use disorder records than HIPAA, requiring specific written authorization for disclosure.

Question 2

What is the purpose of establishing a 'chief complaint' at the start of a clinical evaluation?

Accepted Answer

To capture the client's primary concern in their own words

Answer

The chief complaint documents the client's own description of why they are seeking help, anchoring the evaluation in their perspective.

Question 3

Which withdrawal syndrome is considered the most medically dangerous and potentially life-threatening?

Accepted Answer

Alcohol withdrawal

Answer

Alcohol withdrawal can progress to delirium tremens with seizures and autonomic instability, making it the most life-threatening withdrawal syndrome.

Question 4

When assessing suicidal ideation during a clinical evaluation, which factor increases lethality risk?

Accepted Answer

Active plan with access to means

Answer

Active suicidal ideation combined with a specific plan and access to lethal means significantly increases the risk of a completed suicide attempt.

Question 5

The DAST-10 is a clinical screening tool designed to assess use of which substances?

Accepted Answer

Drugs other than alcohol

Answer

The Drug Abuse Screening Test (DAST-10) assesses consequences and patterns of drug use excluding alcohol, which is separately evaluated with the AUDIT.

NSC Practice Test

NSC Practice Test

NSC Clinical Evaluation 3